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Abstract
Background: Event-related potentials (ERPs) may be used as a highly sensitive way of detecting subtle degrees of
cognitive dysfunction. On the other hand, impairment of cognitive skills is increasingly recognised as a hallmark of
patients suffering from multiple sclerosis (MS). We sought to determine the psychophysiological pattern of
information processing among MS patients with the relapsing-remitting form of the disease and low physical
disability considered as two subtypes: ‘typical relapsing-remitting’ (RRMS) and ‘benign MS’ (BMS). Furthermore, we
subjected our data to a cluster analysis to determine whether MS patients and healthy controls could be
differentiated in terms of their psychophysiological profile.
Methods: We investigated MS patients with RRMS and BMS subtypes using event-related potentials (ERPs)
acquired in the context of a Posner visual-spatial cueing paradigm. Specifically, our study aimed to assess ERP brain
activity in response preparation (contingent negative variation -CNV) and stimuli processing in MS patients. Latency
and amplitude of different ERP components (P1, eN1, N1, P2, N2, P3 and late negativity -LN) as well as behavioural
responses (reaction time -RT; correct responses -CRs; and number of errors) were analyzed and then subjected to
cluster analysis.
Results: Both MS groups showed delayed behavioural responses and enhanced latency for long-latency ERP
components (P2, N2, P3) as well as relatively preserved ERP amplitude, but BMS patients obtained more important
performance deficits (lower CRs and higher RTs) and abnormalities related to the latency (N1, P3) and amplitude of
ERPs (eCNV, eN1, LN). However, RRMS patients also demonstrated abnormally high amplitudes related to the
preparation performance period of CNV (cCNV) and post-processing phase (LN). Cluster analyses revealed that
RRMS patients appear to make up a relatively homogeneous group with moderate deficits mainly related to ERP
latencies, whereas BMS patients appear to make up a rather more heterogeneous group with more severe
information processing and attentional deficits.
Conclusions: Our findings are suggestive of a slowing of information processing for MS patients that may be a
consequence of demyelination and axonal degeneration, which also seems to occur in MS patients that show little
or no progression in the physical severity of the disease over time.
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In most cases, the onset of multiple sclerosis (MS) is
marked by relapses and remissions, termed relapsing-
remitting MS (RRMS), and the majority of patients with
this MS subtype are characterized by a continuous accu-
mulation of disability [1]. On the other hand, there is a
minority of patients who are characterized by having
few relapses at the onset of the disease and an accumu-
lation of modest or no disability over a long period of
time, so they are often described as having a benign
course of MS (BMS). However, this benign prognosis is
currently being discussed [2,3].
Cognitive dysfunction is a frequent finding in patients
with MS [4-6]. Deficits in memory, attention, speed of
information processing and executive functions are typi-
cal and about 30% to 70% of patients experience impair-
ment in these cognitive domains during the course of
the disease [4-6]. Longitudinal studies have consistently
revealed a progression of cognitive impairment over
time in numerous MS disease courses [7,8] even in the
absence of clinical disability [9,10].
During the last few decades, cognitive assessment
using scalp-recorded event-related brain potentials
(ERPs) have proved to be an adequate method and an
objective tool to observe cognitive-related aspects in dif-
ferent neurological diseases. ERPs permit a precise ana-
lysis of the time course of neural events supporting task
performance and can reveal both psychophysiological
correlates of poor performance, providing a unique
insight into information processing.
Whereas early-latency components of ERPs (N1 and
P2) can be used to assess the first stages of information
processing [11,12], the long-latency components of ERPs
(N2, P3 and late deflections after P3) can provide a
more sensitive method for assessing higher-order infor-
mation processing [11-13]. Therefore long-latency com-
ponents have been used more frequently than early-
latency components to evaluate the cognitive complaints
of most neurological diseases. In cognitive-oriented
ERPs studies, the so-called contingent negative variation
(CNV) is of particular interest. The CNV is an event-
related slow negative shift in the human scalp electroen-
cephalogram (EEG) that occurs between two successive
stimuli (a cue stimulus and an imperative stimulus) that
are associated with or are ‘contingent’ on each other. It
is thought that the CNV is able to mirror certain aspects
of motor and cognitive preparation and endogenous
attention [14-16].
It has been previously shown that MS patients display
enhanced latency in both early and late ERP compo-
nents, whereas the amplitude of ERP may also be con-
siderably reduced in the final stages of the disease. The
main studies with MS patients have reported abnormal-
ities in the latency or the amplitude of late ERP
components, such as N2 or P3 [17-20], but also in early
ERP components such as N1 or P2 [17,18,21]. These
results have been interpreted, and supported by neurop-
sychological and neuroimaging evidence, as a general
objective index of cognitive impairment in MS patients,
characterized by slow information processing, as a result
of disconnections between cortical-subcortical and cor-
tico-cortical structures [17,18,22-24].
Most of these results using ERPs in MS disease have
been elicited during discriminatory tasks, classically odd-
ball tasks. However, new studies using more refined
tasks may explore other impaired cognitive domains or
detailed aspects in the information processing from a
psychophysiological approach [24]. In particular, the
study of attention mechanisms using the central cue
Posner paradigm [25,26] could be a powerful tool to
explore basic processes underlying more complex infor-
mation processing skills in these patients. The central
cue Posner paradigm allows studying the deployment of
attention to certain positions in space [16,27] from a
behavioural and psychophysiological point of view.
The motivation for the present study was to investi-
gate the information processing patterns and abnormal-
ities of attentional mechanisms associated with the
Posner paradigm both in benign and typical relapsing-
remitting forms of MS disease. To our knowledge, there
are no published studies regarding the temporal
dynamics of CNV associated to a Posner task in MS dis-
ease. According to previous psychophysiological studies
[28,29], we suggest that patients with a benign profile of
MS also manifest altered cognitive processing that may
be different from that which patients with a typical
relapsing-remitting course demonstrate. Furthermore,
and consistent with current evidence about the natural
course of MS disease [1,2], we suggest that the dete-
rioration of different cognitive mechanisms is masked
throughout the relapsing-remitting course of MS despite
minimal physical disability. Additionally, and in an effort
to explore natural subgroups of MS patients from a dif-
ferent perspective, we conducted a cluster analysis to
establish particular grouping of individuals on the basis
of their common psychophysiological pattern and cogni-
tive profile and whether this particular grouping might
also be related to clinical parameters.
Methods
A previous paper [28] incorporates subsets of the data
presented here, focusing on the contribution to prelimin-
ary psychophysiological results in different groups of MS
disease. The current study incorporates new in-depth
psychophysiological measures as well as more refined sta-
tistical analysis in order to identify a relationship between
the studied measures and the identification of natural
subgroups based on psychophysiological measures.
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Clinical, behavioural and ERP data were collected from
twenty-seven MS patients, clinically defined according to
the Poser criteria [30], and classified in two clinical sub-
groups: (1) seventeen had typical relapsing-remitting MS
(RRMS), defined as a history of several relapses and
remissions and with disabil i t yo nt h eK u r t z k eE x p a n d e d
Disability Status Scale (EDSS) [31] less than 3.5; (2) ten
had a profile of benign MS (BMS), defined by a relap-
sing-remitting onset, but a disease course of more than 8
years without relapses and remissions and with an EDSS
of less than 3. Other inclusion criteria of our study were:
clinical remission of the disease in the last three months
prior to the study; and absence of corticosteroid treat-
ment for at least three months. Patients were excluded if:
a major depressive disorder had begun after the onset of
MS, if patients showed any other CNS disorder, or meta-
bolic, psychiatric, learning disorders; or in the presence
of physical impairment (motor and visual) that might
have interfered with testing. Lastly, we must highlight
that overall, the MS patients included had no immuno-
modulation record before beginning our study.
Patients were previously assessed at the Multiple
Sclerosis Unit of the Neurology Unit of the Virgen
Macarena Hospital (Seville, Spain) and participated
voluntarily in the psychophysiological testing. All partici-
pants signed informed consent before their inclusion in
the study and the protocol was approved by the ethics
committees of the participating hospital and the Univer-
sity of Seville. Participants included in this study formed
the same dataset as that used in Gonzalez et al, 2006. MS
patients were matched with a healthy control group for
age, sex and educational level with a healthy control
group. In addition to these variables, age at disease onset,
disease duration, and EDSS scores were collected for all
MS patients. Table 1 details the demographic and clinical
MS variables of all participants in this study.
Stimuli and Procedures
All stimuli were presented on a black computer screen
that was viewed from a 70-cm distance. Subjects sat in a
chair in front of the video monitor displaying the visual
stimuli in a sound-attenuated room with dimmed lights.
They were asked to fix their eyes on the central fixation
(a white cross) and to remain as quiet as possible. Parti-
cipants were asked to detect and respond to a visual tar-
get stimulus (a black and red checkerboard) and to
ignore and not respond to a standard visual stimulus (a
black and white checkerboard). Both stimuli were pre-
ceded by a central directional cue.
A detailed description of the experimental paradigm
can be found in references 26 and 28. For a basic
description please see the footnote in Figure 1.
ERP recording procedures and measurements
EEG recordings were obtained using 13 scalp sites from
an electrode cap (Electrocap™) according to the Inter-
national 10-20 electrode system. Blinks and saccades
were controlled using vertical and horizontal electroocu-
logram (VEOG and HEOG) and were recorded with
bipolar recording by means of electrodes situated in the
external canthi of the ocular orbits and in the inferior
and superior positions of the left orbit. All electrodes
were referenced to the left mastoid and re-referenced
off-line to the linked mastoid and the ground electrode
was placed on the mid-forehead. The amplification gain
was 20,000 (Neuroscan, Grass) and data were filtered
using a band-pass of 0.01-100 Hz. EEG was digitised at
a frequency rate of 500 Hz and the impedance was kept
below 5 kOhm. Previous to average calculation, each
EEG epoch was visually inspected and epochs containing
excessive movement or EEG artefacts were rejected.
Additionally, trials in which HEOG artefacts were higher
than ± 60 μV were rejected. The period of 100 ms pre-
vious to standard/target stimuli was considered as the
baseline for standard/target ERP analysis. A new base-
line of 100 ms prior to the cue stimuli was computed
for the CNV analysis. The different experimental condi-
tions were averaged independently.
Behavioural measures
Various measures were recorded to assess behavioural
performance for each participant. Reaction times (RTs)
Table 1 Demographic and MS clinical variables of all participants
Groups
CONTROLS RRMS BMS p
N 18 17 10 - - -
Sex(female) 15 (83%) 12 (80%) 6 (60%) 0.716
Education (years) 10.67 ± 2.3 9.9 ± 3.9 9.2 ± 3.1 0.537
Age 36.54 ± 8.73 [26-54] 38.88 ± 9.04 [24-63] 42.30 ± 7.21 [28-56] 0.247
Age at onset - - - 34.12 ± 6.5 [23-44] 30.90 ± 6.9 [21-42] 0.414
EDSS - - - 2.1 ± 1.3 [0-3,5] 1.6 ± 0.9 [1-3] 0.609
Disease Duration - - - 4.67 ± 4,13 [1-18] 12.09 ± 4.77 [8-16] 0.001
Mean, standard deviation, and range are shown for age, age at onset, disease duration and EDSS score. Sex (% female) and years of education are also shown.
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rect responses (% CRs) were obtained. The percentage
of error (% Errors) was also analysed. An error was con-
sidered if: no response to the target occurred, or the
response occurred 700 ms after target stimulus (missed);
when responses to the targets occurred with the wrong
finger (target error); and when the response was to stan-
dard stimuli (false positive). For the percentage Error
analysis (due to great ratio of valid stimuli in compari-
son to invalid stimuli), the difference between number
of stimuli of each condition were computed using a
ratio-adjusted percentage.
ERP measures
ERP components were functional and operationally
defined on the basis of previous research, in terms of
experimental task effects in a specified latency range
and in specific scalp locations. For all ERP components
the variables considered were the baseline-to-peak
amplitudes and the stimulus-to-peak latencies. These
measured time windows were determined on the basis
of inspection of the grand average waveforms in the
control group. The amplitude of each ERP component
was measured within latency windows centred on the
peak latency of the grand average ERPs.
In order to determine relevant time windows of ampli-
tudes and latencies of the ERP components, peak analy-
sis was separately performed for the standard and target
stimuli and during the CNV period. Thus, for standard
stimuli, early N1 (eN1), P1, N1, P3 and late negativity
(LN) components were measured. Different ERP compo-
nents were only analyzed when they appeared. In the
case of target stimuli, it was not possible to analyze P1
and N1, probably due to the lack of an adequate signal-
to-noise ratio, given the low number of target stimuli.
However, P2, N2, P3 and LN were measured. Each ERP
component was obtained for each subject as the greatest
Figure 1 Experimental paradigm. A modified version of the central-cue Posner’s paradigm. 75% standard stimuli, 25% target trials. Five blocks
with 200 trials each were presented. All stimuli last for 300 milliseconds (ms). The presentation of stimuli was random (left or the right side).
Target and Standards were presented at 2.46 degrees to the left or the right of the central fixation point. Cues could point towards the position
where the stimulus appears (valid trials, 80%) or the opposite side (invalid trials, 20%). The subject’s task was to indicate the appearance of the
target stimulus in the left or right visual field by pressing the left button or right button. Therefore, left valid, left invalid, right valid and right
invalid trials appeared both for standard and target trials.
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on typical electrodes in the appropriate time window
(for an example of procedure, see Gonzalez-Rosa et al,
2006). LN component was defined as the highest nega-
tive deflection between 400 and 500 ms immediately
after the P3 wave on the ERP, and amplitude was mea-
sured at frontal, central and parietal electrodes from dif-
ference waveforms obtained by subtracting invalid minus
valid trials of average ERPs both in the target and stan-
dard condition.
For the measurement of CNV, three areas of interest
were defined at three different time windows and their
amplitudes were calculated with respect to a baseline
(100 ms prior to the cue stimulus). Immediately after
the sensory ERPs induced by the cue stimulus, an acute
negativity between 400 and 600 ms was presented. This
early or initial phase of the CNV was termed eCNV and
was defined as the highest negative deflection at this
time window on central and parietal scalp locations.
The central phase of the CNV (cCNV) was defined as
the mean negative amplitude on fronto-central electro-
des between 600-1000 ms after the cue stimulus. On the
late part of the CNV, a slow negative potential appeared
during the time preceding the imperative stimuli. This
late or terminal period of the CNV (tCNV) was defined
as the mean negative amplitude in the time window 500
ms preceding the imperative stimuli on occipital scalp
locations.
Statistical analysis
A mixed design, factorial, and repeated measures analy-
sis of variance (ANOVA) was used to analyse the beha-
vioural performance by means of RTs, %CRs and Errors
data. For RTs and %CRs analysis, the within-subject fac-
tors were the condition validity of the cue (valid vs.
invalid) and side of presentation of the target (left vs.
right), and the between-subject factor was the subject’s
group ( R R M Sv s .B M Sv s .C o n t r o l s ) .I nt h ec a s eo f%
Errors, we used the same statistical design although side
of presentation was replaced with type of error (misses
vs. target error vs. false positive).
For all ERP comparisons, voltage measurements in dif-
ferent electrodes were taken for each ERP component
and introduced in the ANOVA. Therefore, electrode fac-
tors could be represented by frontal, central, parietal,
occipital or temporal localizations according to defini-
tions of each ERP component, whereas hemispheric fac-
tor could be constituted by left, right or midline
hemispheric localizations. Moreover the factors, side of
presentation of the stimuli (left vs. right) and validity of
the cue (valid vs. invalid) were introduced into the
ANOVA as within-subject factors when appropriate.
The between-subjects factor was always grouped in
three levels (RRMS vs. BMS vs. Controls).
In the case of CNV, separate repeated-measures
ANOVAs for each CNV period were performed with a
new within-subject factor cued side (left vs. right) as
well as electrode (frontal vs. central vs. parietal vs. occi-
pital) and hemispheric (left vs. midline vs. right hemi-
spheric) factors. For LN wave, the same statistical
analyses were conducted for both standard and target
stimuli using frontal, central and parietal electrodes, but
the side of presentation factor was collapsed to maximize
effects in order to achieve adequate signal-to-noise ratio.
Since ERP latencies followed a normal distribution,
parametric tests were applied. When appropriate, the
Geisser-Greenhouse (G-G) procedure was applied to
correct degrees of freedom. Post hoc comparisons (t
tests and Bonferroni test) were performed when
ANOVA yielded significant results. A level of p ≤ 0.05
was accepted as statistically significant.
Correlations
Behavioural (RTs, %CR and % errors) and psychophysio-
logical data (amplitude and latency) of different ERP
components were correlated with clinical variables
(EDSS and disease duration) in MS patients using Pear-
son’sa n dS p e a r m a n ’s correlation coefficients where
necessary. Previously, partial correlations adjusted for
age were used to screen psychophysiological variables
for their relationship with EDSS and disease duration.
For amplitude and latency measures, if an ERP compo-
nent obtained several good correlations in different elec-
trodes, we chose the maximum values for each ERP
component.
Cluster analysis
Cluster analysis was performed in order to identify the
natural occurrence of subgroups of patients with similar
properties according to their behavioural and psycho-
physiological characteristics. A 2-stage cluster analysis
[32] was used to build up the cluster solution, i.e. hier-
archical clustering followed by non-hierarchical
clustering.
Initially, the behavioural and psychophysiological data
from the MS patients were converted to Z-scores based
on the data from the control group in order to ensure
equal weighting of different symptoms in the clustering
procedure. The variables introduced in the cluster analy-
sis were those which most clearly discriminated between
groups in terms of statistical significance (p > 0.035)
after performing ANOVA analysis. The first step of this
cluster analysis employed a Ward’sm e t h o do fm i n i -
mum-variance (hierarchical) to explore and to deter-
mine the number of clusters and thus to provide the
initial solution for the second step. Since outliers might
severely distort the results of cluster analysis, in this
first step some participants were identified as outliers
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regard to the others clusters) and removed from the fol-
lowing statistical step. The second step employed a K-
means cluster analysis (non-hierarchical) using the near-
est neighbour joining method computing Euclidean dis-
tances among all participants.
K-means procedure separates subjects into a pre-spe-
cified number of cluster groups. The procedure allows
some flexibility in terms of choosing different indicator
variables and numbers of clusters to be formed. The
present study also followed some recommendations
[32,33] to validate the proposed clustering solution: par-
titioning of clustering variables; validating the clustering
solution, and profiling the clustering solution with vari-
ables other than those in the clustering procedure.
Finally, in order to verify whether the clusters were
really different from one another, we subsequently per-
formed a new descriptive analysis and an ANOVA with
the clusters as between-subjects factors and the new Z-
scores as within-subjects. Post-hoc analysis to compare
each cluster with the other for every cognitive Z-score
of behavioural and psychophysiological measures was
carried out taking into account a significant difference
of p < 0.05.
Results
Behavioural data
Table 2 summarizes the behavioural results after appli-
cation of the Posner task for both control and MS
groups. These behavioural data were partially reported
in a previous study [28] although new analyses were
computed in this study.
MS groups obtained a worse performance than the
control group with higher RTs (F (2,42) = 14.947, p <
0.001) and a lower CRs percentage (F (2,42) = 6.790, p
= 0.003). Between MS groups, BMS patients showed
p o o r e rr e s u l t st h a nR R M Sp a t i e n t sa sw e l la sal a c ko f
validity effect (RTs invalid minus RTs valid condition).
Furthermore, the analysis of Errors percentage
(missed, target error and false positive), after partial-
weight correction between valid and invalid trials,
revealed that there was a significant error x group effect
(F (4,86) = 5.780, p = 0.005) caused by the fact that MS
patients obtained a higher amount of errors. Post-hoc
tests proved that there was a significantly higher error
rate in the BMS group in comparison with the other
two groups for missed-error type (RRMS: p = 0.040;
Controls, p = 0.005), which largely represents the lack
of accuracy in the benign patients. In general, and for
all groups during the task performance, the most impor-
tant error type was the missed-error for invalid trials
(validity of the cue x type of error effect: (F (2,86) =
11.279, p < 0.001), whereas the false positive-error type
was practically absent in all groups.
Event-related potentials
T h eC N Vw a v e f o r m sa r es h o w ni nF i g u r e2a n dt h e
grand-mean ERPs elicited by the visual standard and
target stimuli and the difference waveforms are dis-
played in Figure 3. After the cue stimulus, three CNV
periods were clearly identified on the grand average,
whereas with the arrival of standard or target stimuli,
typical ERP components were developed. The standard
stimuli elicited an early inflection previous to the P1
component which we termed as frontal eN1 (mean
latency = 120 ± 9 ms), P1 component (mean = 133 ± 5
ms), N1 component (mean = 174 ± 11 ms) and P3 com-
ponent (mean = 352 ± 12 ms) components. On the
other hand, the target stimuli elicited a frontal and cen-
tral P2 component (mean = 222 ± 10 ms), N2 compo-
nent (mean = 257 ± 11 ms) and P3 component (mean =
368 ± 19) components. Moreover, both standard (mean
= 410 ± 21 ms) and target (mean = 443 ± 19 ms) sti-
muli elicited a negative late negativity (LN) component
over midline after the P3 component.
The new factors and levels introduced in the statistical
analysis in comparison with that of our preliminary
study using only standard stimuli and some ERPs com-
ponents [29] did not show any new group effects for
this type of stimuli.
CNV period and ERP Amplitude
Table 3 summarizes some results related to amplitude.
In relation to the CNV period, a typical increased
Table 2 Mean reactions times (RTs), percentage of correct
responses (% CRs) and percentage of errors (% Errors)
for different groups
Groups
Behavioural Controls * RRMS * BMS p
RTs (ms) Valid 433 ± 50 492 ± 47 549 ± 63 -
Invalid 467 ± 56 510 ± 43 560 ± 45 –
Total 450 ± 53 501 ± 43 555 ± 51 <0.001
a,b,c,d
% CRs Valid 96 ± 4 94 ± 5 81 ± 23 –
Invalid 97 ± 5 92 ± 7 79 ± 21 –
Total 96 ± 5 93 ± 6 80 ± 23 0.003
a
% Errors Valid 1 3 8
Invalid 3 4 12
Total 4 7 20 0.005
a,b,c
a = between control and MS groups but not differences between both MS
groups;
b = between RRMS and BMS groups, after post-hoc analysis;
c = between control and BMS groups, after post-hoc analysis;
d = between control and RRMS groups, after post-hoc analysis;
* = Groups who showed statistical differences for validity of the cue (invalid >
valid)
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landscape of both periods was highly similar for eCNV,
cCNV and tCNV periods between control and MS
groups. However, there was a significant interaction
group x hemispheric x electrodes (F (2,42)= 2.962, p =
0.035) for eCNV. Post-hoc analyses revealed that BMS
group had a smaller amplitude (i.e., most positive-going)
in comparison with the control group for central elec-
trodes of (p = 0.031) and parietal electrodes of right
hemispheric (p = 0.045). Post-hoc analyses also showed
that there were no differences between RRMS and con-
trols, respectively, or between the two MS groups.
R e g a r d i n gc C N Vp e r i o d ,t h e r ew a sam a i ne f f e c to f
group (F (2,42) = 3.385, p = 0.043), showing that RRMS
patients had a significant increase (more negative) of
mean cCNV amplitudes on frontal electrodes in contrast
to the control group (p = 0.045). However, there were
no significant differences in relation to tCNV amplitudes
between different groups. There was a main electrode
effect (F (2,42) = 12.589, p < 0.001), indicating that the
component showed typical modulations and it was
significantly higher (i.e. most negative-going) in poster-
ior sites than anterior sites of the scalp.
Visual inspection of grand-average waves suggested
that amplitude of ERP components to standard stimuli
(P1, N1 and P3) and to target stimuli (P2, N2 and P3)
were fairly well preserved in both groups of MS patients.
However, this did not occur for the frontal eN1 compo-
nent elicited by standard stimuli, which had a more
negative amplitude in the control group, whereas a posi-
tive deflection appeared for the MS groups. Statistical
analysis confirmed a significant main group effect on
this component on middle line and right hemispheric
over frontal regions for controls compared with MS
patients (F (4,84) = 11.303, p < 0.001), whereas there
was no differences between MS groups.
Although the grand means data of P1 showed typical
modulations of attention effect with Posner tasks
(enhanced amplitude of P1 for valid and attended condi-
tion in comparison with invalid and not attended condi-
tion), this effect was not statistically confirmed (F (1,42)
= 1.523, p < 0.224). There was an interaction effect of
Figure 2 Event-Related Potentials (ERP) elicited by cues and the subsequent CNV period for the three groups in different positions of
the scalp. The black arrow indicates when the cue stimulus is presented and the black arrow with an asterisk when the imperative stimulus is
presented. The marked black lines represent: eCNV, cCNV and tCNV periods.
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= 4.295, p = 0.020). Control and RRMS groups showed
higher amplitudes for valid trials compared to invalid
trials, which was not observed in the BMS group who
showed the highest amplitude of all groups for invalid
trials, however, post-hoc comparisons did not confirm
this group effect.
Both N1 and P2 components did not show group
effects for amplitude. However, the P2 component
showed in all groups, that stimuli preceded by invalid
trials had higher amplitude respect to stimuli preceded
by valid trials (validity of the cue effect: (F (1,42) =
12.847, p < 0.001) and over frontal electrodes in com-
parison with central electrodes (electrode x hemispheric
effect: (F (2,84) = 3.536, p = 0.034). Equally, although
the control group clearly exhibited a larger average of
N2 amplitude than both MS groups for target stimuli
(mean amplitude = Controls: -0.41 ± 3.5 μV; RRMS:
1.39 ± 3.7 μV; BMS: 2.18 ± 4.4 μV), this was not statisti-
cally significant (F (2,42) = 1.857, p = 0.169), probably
caused by a high intersubject variability in all groups. In
g e n e r a l ,ah i g h e rn e g a t i v ea m p l i t u d ew a so b s e r v e di n
central regions in comparison with frontal regions (elec-
trode effect: F (1,42) = 14.743, p < 0.001), and for right
hemispheric compared to left hemispheric positions
(hemispheric effect: (F (2,84) = 3.814, p = 0.028).
Significant between-group differences in the amplitude
P3 component were not observed in either the standard
or target stimuli. All groups obtained higher amplitudes
for invalid vs. valid trials for target stimuli in the ampli-
tude P3 component with maximum effect in parietal
r e g i o n so fm e a nl i n ei nc o m p a r i s o nw i t ho t h e rs c a l p
positions analyzed (F (6,252) = 2.734, p = 0.034). How-
ever, for standard stimuli, and in spite of the BMS
group not obtaining higher amplitudes for invalid vs.
valid trials with standard stimulation (in comparison to
RMSS or control groups), statistical differences were not
found with respect to the validity of the cue between
groups for the amplitude of the P3 component.
The LN amplitude after subtraction (invalid minus
valid) showed a central-parietal dominant LN at latency
of 400-500 ms (mean = 447 ± 19 ms) in all groups
Figure 3 Event-Related Potentials for different groups associated to: a) standard stimuli, b) target stimuli, and c) valid and invalid
cues for target stimuli period for three groups in different scalp positions. In the right column the period (black lines) where the LN was
analyzed and the voltage maps for difference waveform are showed. The black arrow demonstrates when the imperative stimulus is presented.
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Page 8 of 19which was also clearly higher to target stimuli compared
with standard stimuli (F (5,210) = 4.217, p = 0.006).
Only ANOVA for target stimuli of the LN component
revealed a significant group effect (F (2,42) = 3.773, p =
0.031) caused by the fact that, over the central midline,
the LN component was larger in amplitude (most nega-
t i v e - g o i n g )i nt h eR R M Sg r o u pt h a ni nt h eB M Sg r o u p
(p = 0.028) but there were no differences compared
with the control group (p = 0.399). Finally, LN
amplitude showed that, both for standard (hemispheric
effect: (F (2,84) = 6.321, p = 0.007) and target stimuli
(hemispheric x electrode effect: (F (4,168) = 3.446, p =
0.024), central regions had higher amplitude with
respect to frontal or parietal regions.
ERP Latency
Table 3 summarizes the results related to latency. The
ERPs to standard stimuli were P1, N1 and P3 compo-
nents. The ANOVA on the latency of the standard-
Table 3 Amplitude and latency of ERP components for target and standard stimuli and for the CNV periods
Amplitude Latency
Controls RRMS BMS p Controls RRMS BMS p
ERPs Mean ± SD ERPs Mean ± SD
(○) eN1 0.001
a
Valid -0.85 ± 2.4 0.47 ± 1.2 0.97 ± 1.2
Invalid -0.63 ± 0.9 0.33 ± 1.5 0.96 ± 2.1
(○)P 1 0.020
a,b,c (○) P1 0.558
Valid 1.59 ± 1.8 1.86 ± 1.3 1.59 ± 1.0 132 ± 6 135 ± 6 136 ± 7
Invalid 1.17 ± 1.5 1.19 ± 1.2 2.09 ± 2.1 133 ± 7 133 ± 5 133 ± 6
(○) N1 0.419 (○)N 1 < 0.001
a,c
Valid - 0.95 ± 1.2 - 1.41 ± 1.1 - 1.01 ± 1.7 174 ± 11 179 ± 10 188 ± 8
Invalid -0.98 ± 1.5 -1.46 ± 1.1 -0.81 ± 1.5 173 ± 11 181 ± 10 188 ± 9
(○) P3 0.294 (○)P 3 0.003
a,b,c,d
Valid 4.99 ± 2.4 4.38 ± 4.8 4.56 ± 2.7 352 ± 1 371 ± 10 381 ± 18
Invalid 5.67 ± 1.4 5.18 ± 1.5 4.61 ± 2.5 353 ± 13 375 ± 17 390 ± 12
(⊙) P2 0.232 (⊙)P 2 < 0.001
a
Valid 5.40 ± 2.8 5.37 ± 3.3 5.26 ± 3.7 219 ± 12 240 ± 13 241 ± 17
Invalid 5.99 ± 3.7 6.25 ± 2.7 7.25 ± 1.5 226 ± 11 242 ± 12 249 ± 13
(⊙) N2 0.169 (⊙)N 2 0.002
a
Valid -0.30 ± 1.7 -0.16 ± 1.8 -0.52 ± 3.8 252 ± 13 268 ± 10 271 ± 17
Invalid -0.10 ± 2.6 -0.81 ± 2.4 -0.40 ± 3.1 262 ± 11 270 ± 12 269 ± 12
(⊙) P3 0.239 (⊙)P 3 < 0.001
a
Valid 8.95 ± 3.7 7.63 ± 4.3 7.13 ± 4.4 372 ± 19 397 ± 15 399 ± 20
Invalid 9.81 ± 3.9 8.36 ± 4.1 9.22 ± 4.2 363 ± 20 381 ± 20 390 ± 17
(○) LN -1.72 ± 1.1 -1.80 ± 1.5 -1.68 ± 1.5 0.718
(⊙) LN -2.23 ± 2.1 -3.24 ± 2.0 -1.13 ± 1.5 0.031
b
eCNV -1.82 ± 1.7 -0.87 ± 1.1 -0.18 ± 2.2 0.035
a, c
cCNV 1.13 ± 0.8 -0.57 ± 0.8 0.89 ± 1.0 0.043
a, d
tCNV 0.57 ± 0.6 0.96 ± 0.7 0.74 ± 0.9 0.632
Means and standard deviations (SD) of electrodes and regions of interest used for each ERP-component ANOVA analysis are shown. P values show main
statistical effects involving the group factor.
[⊙ = target stimuli; ○ = standard stimuli].
a = p < 0.05 between control and both MS groups;
b = p < 0.05 between RRMS and BMS groups;
c = p = < 0.05 between control and BMS groups;
d=p < 0.05 between control and RRMS groups.
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Page 9 of 19evoked P1 revealed that there was no effect of group
between different groups (F (2,42) = 0.591, p = 0.558)
and that there was a significant interaction side of pre-
sentation x hemispheric x electrode (F (2,84) = 12.226, p
< 0.001) caused by the fact that faster latencies are
obtained over contralateral regions of the side of presen-
tation of the stimuli as compared to ipsilateral regions,
and also because the P1 latency is contralaterally faster
on the right (vs. left) side of stimulus presentation and
over temporal and occipital (vs. parietal) areas. However,
N1 component showed a group x electrode interaction
effect (F (4,84) = 8.927, p < 0.001), indicating post-hoc
comparisons that BMS patients had a larger N1 latency
than the control group over parietal (p < 0.001) and
occipital (p < 0.001) sites. RRMS patients did not show
differences in N1 latency compared with controls or
BMS patients.
With respect to P3 latency of standard stimuli, there
was also a statistically significant interaction group x
electrode (F (6,126) = 5.149, p < 0.003), indicating that
the P3 latency of the control group was faster than both
MS groups (p < 0.001 respectively) over all scalp sites
analyzed, whereas RRMS had a faster P3 latency than
t h eB M Sg r o u po n l yo v e rc e n t r a l( p =0 . 0 3 3 )a n dp a r i e -
tal (p = 0.015) areas. Despite the invalid trials (vs. valid
trials) showing significantly longer P3 latencies both for
controls and MS patients, this was not confirmed
statistically.
ERP to target stimuli consisted of P2, N2 and P3 com-
ponents. P2, N2 and P3 latencies showed a strong main
group effect between controls and MS patients, but not
between MS groups. Therefore, both MS groups had
equally affected P2, N2 and P3 latencies. Thus, controls
were faster for P2 latency (F (2,42) = 18.246, p <0 . 0 0 1 ) ,
N2 latency (F (2,42) = 6.987; p = 0.002) and P3 latency
(F (2,42) = 10.153, p < 0.001) than both MS groups,
although post-hoc analysis did not show differences
between RRMS and BMS groups.
In general, invalid trials of target-ERP components
obtained longer latencies in all groups. There was also a
significant interaction hemispheric x validity of the cue x
group on the P3 latency (F (4,84) = 2.688, p = 0.047),
whose post-hoc t-tests indicated that the Control group
had shorter latencies compared with the RRMS group
to valid stimuli over midline (p < 0.001) and left hemi-
spheric (p = 0.001) sites, whereas the control group
obtained shorter latencies compared with the BMS
group to invalid stimuli over midline (p < 0.001) and
right hemispheric (p = 0.005) sites of the scalp.
Since there were few trials with target stimuli and
probably reduced noise-signal, P1 and N1 components
were not analyzed. However, there was no group effect
on the latency of LN that appeared following the P3
component for both standard and target stimuli.
Correlations
The MS clinical variables were correlated with beha-
vioural and ERP data. Our results showed that a statisti-
cally significant correlation was not observed between
EDSS scores and any behavioural or psychophysiological
measure. Despite several apparently strong correlations
between disease duration and latencies in different ERP
components (e.g., between disease duration and P3: r =
0.790, p = 0.001), most of these correlations did not
remain significant after partial correlations were
adjusted for age. P2 (r = 0.506, p = 0.008) and N1 (r =
0.500, p = 0.009) latencies were the only measures that
maintained moderate correlations after being adjusted
for age.
Cluster analysis
The first step of the cluster analysis suggested three to
four clusters to explain the present sample, after remov-
ing outliers. Initially, a three cluster solution appeared
most suitable (as controls fell into an intact cluster and
all MS patients fell into two separate clusters), however,
a four cluster solution was selected as healthy partici-
pants strongly tended to split into two different clusters,
practically without affecting the patient clusters from
the three cluster solution. This approach allowed
exploration of the characteristics that divided the con-
trol group.
Therefore, a four-cluster solution was chosen as the
optimal solution with the outlier subjects removed from
analysis after an examination of Euclidean distances
between cluster centres, the between-cluster mean
squares, and the within-cluster mean squares, and
adopting the suggested procedures for validating the
clustering solutions for K-means cluster analysis [32,33].
In addition, subsequent ANOVAs and post-hoc analyses
(with the clusters as between-subject factor and Z-scores
as within-subjects factors) revealed that the differences
were highly significant for the included parameters.
The profiles of the four groups are summarized in
Figure 4 and Table 4. Cluster 1 took up 50% of the con-
trols only, whereas Cluster 2 accounted for 50% of con-
t r o l s ,1 1 . 8 %o fR R M Sa n d1 0 %o ft h eB M Sp a t i e n t s .
Cluster 3 and Cluster 4 only consisted of MS patients.
Thus, Cluster 3 accounted for 68% of the total RRMS
patients’ sample of our study as well as 30% of BMS
patients, whereas Cluster 4 accounted for 17.4% of
RRMS patients and 40% of BMS patients.
Significant differences were found among Cluster 2
and Cluster 1 (over 1.5 or 2 standard deviations) in
terms of latency for P2 (p < 0.001) and P3 (p < 0.001).
Cluster 1 was different (p > 0.001) from Cluster 3 for all
latency-scores as well as RT score (p = 0.024) and for
early frontal N1 (p = 0.005), eCNV (p = 0.019) and
cCNV (p = 0.039) amplitude-scores. Moreover, Cluster
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sured. Cluster 2 was similar to Cluster 3 in terms of
behavioural performance, although they were different
for latency-scores of P3 (p <0 . 0 0 1 )a n do fP 2( p =
0.009), as well as for amplitude-scores of frontal eN1 (p
= 0.038) and LN (p = 0.048). Cluster 3 was different
from Cluster 4 for all behavioural and latency scores
and for LN amplitude (p = 0.012) but not for eCNV and
frontal eN1 amplitude-scores.
Cluster 1 seemed to include the younger subjects of
the control group (28.4 ± 5.7) than those in Cluster 2
(36.0 ± 9.7), although it was not statistically significant.
Clusters accounting for MS patients were not different
in terms of age, disease duration or EDSS score. In any
case, it was observed that clusters consisting of patients
with a worse psychophysiological performance also had
a longer disease course. EDSS scores did not show dif-
ferences between clusters.
It is also important to highlight that outliers’ cases
account for 20% of benign patients who were character-
ized by longer disease duration, a very poor behavioural
performance and an abnormal psychophysiological pat-
tern in terms of several standard deviations in compari-
son with other clusters.
Discussion
In the present study we used an attentional visual-spa-
tial task with central cues, the so-called central cue Pos-
ner’s paradigm, in order to investigate the altered
cognitive processing in two subtypes of MS patients and
controls. At the same time we explored the nature and
pattern of these cognitive abnormalities and their rela-
tionship with clinical variables using a multivariate sta-
tistical approach.
Behavioural performance
MS patients demonstrated a slower response speed than
controls when detecting the mere presence of a stimulus
previously cued (attentional orienting) as well as when
they had to detect a stimulus which appeared over the
opposite cued site (attentional reorienting).
Our results replicate other studies in healthy subjects,
which have observed an increase of RT for an invalid
cueing condition compared with a valid cueing condi-
tion [25,26,34]. Orienting to cues provides information
about where the target will occur, with consequent ben-
efits for RT. It is expected that the processing of a target
stimulus that is not previously cued, takes longer, or
causes more errors, than that of a cued target stimulus.
Figure 4 Profiles of psychophysiological findings for the four clusters.[ ⊙ = target stimuli; ○ = standard stimuli] Collectively, these findings
suggest that the relapsing-remitting course of MS appears to form a more homogenous group of patients in this disease while the benign
course of MS forms a more heterogeneous group in terms of altered cognitive processing. Thus, RRMS patients appear to have a relatively
preserved behavioural performance with mild/moderate abnormalities of early-latency ERP components and moderate/severe impairment for P3
latency. However, our findings also show that some RRMS patients may develop important cognitive disturbances during typical relapsing-
remitting stages of the disease. On the other hand, BMS patients tended to demonstrate a high heterogeneity according to their
psychophysiological abnormalities. Thus, BMS patients clustered into Cluster 2 without signs of cognitive impairment and into Cluster 3 with
moderate cognitive disturbances. Furthermore, BMS patients even fell into outlier cases with more severe abnormalities.
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but patients of the BMS group did not.
Results obtained by BMS patients cannot be easily
attributed to a deficit in the disengaging of attention,
since these patients obtained a similar RT in valid and
invalid condition. Their performance could be attributed
rather to a deficit in engaging attention or follow-up of
cue, since they seem to deal with all stimuli equally.
Similarly, these differences cannot be explained by a
speed-accuracy trade-off because MS groups were also
less accurate than the control group. Both RRMS and
BMS groups had significantly lower CR percentage and
Table 4 Values represent mean standardized scores for cluster centers after computing k-means cluster analysis
Cluster 1 Cluster 2 Cluster 3 Cluster 4 Outliers
CONTROLS =
50%
CONTROLS = 50% RRMS = 11.8%
BMS = 10%
RRMS = 68% BMS =
30%
RRMS = 17.4% BMS =
20%
BMS =
20%
p post-hoc
Demographics
Age 28.4 ± 5.7 36.0 ± 9.7 40.7 ± 9.4 38.8 ± 4.1 56 ± 0.0
Dis.
duration
5 ± 6.1 6.2 ± 4.6 7.4 ± 3.8 14.1 ±
3.5
EDSS 1.8 ± 1.44 2.1 ± 0.8 1.8 ± 4.7 2.7 ± 0.3
Behavioural
RTs -0.222 0.344 0.908 2,094 <0,001 bcef
%CRs 0.287 -0.191 -0.632 -3,366 <0,001 cef
ERP Latency
(○)N 1P4 0.024 0.236 1,817 2,475 <0,001 bcde
(⊙)P 2Fz -0.817 0.877 1,736 2,696 <0,001 abcd
ef
(○)P 3Fz -0.556 0,478 2,096 2,921 <0,001 abcd
e
(○)P 3Cz -0.652 0.763 2,988 3,897 <0,001 abcd
ef
(○)P 3Pz -0.734 0.869 3,133 4,056 <0,001 abcd
ef
(⊙)P 3Fz -0.438 0.466 0,863 2,092 <0,001 abcef
(⊙)P 3Cz -0.579 0.624 1,373 2,350 <0,001 abcef
(⊙)P 3Pz -0.607 0.582 1,054 2,041 <0,001 abce
ERP
amplitude
eCNVCz
eCNVP4 -0.034 0.052 0,466 0,909 0,038 c
cCNVFz -0.186 0.063 0,850 -0,221 0,047 c
(○) eN1Fz 0.232 0.019 -0,652 -0,221 d
(⊙)N 2 Cz 0.002 0.293 1,370 1,109 0,002 bcd
(⊙)L N Cz -0.331 0.043 -0,758 0,368 0,054 -
(⊙)L NC4 -0.122 0.138 -0,626 0,726 0,018 cdf
-0.026 0’066 -0,398 -0,028 0,639 -
Significant p values of a new cluster-related ANOVA (using Z-scores as within-subject factors and the different clusters as between-subject factor) are also
displayed. The percentage of cases and the contribution of each different experimental group to cluster solutions are also shown. Outlier cases are shown but
they were not included in the new ANOVA. In general, ERP latencies had a great weight on splitting the clusters than ERP amplitudes. New demographic values
(mean and SD) for age, disease duration and EDSS scale are also shown for each cluster. Differences between clusters for demographic values were not found.
Different statistical differences were found between clusters as follows:
[⊙ = target stimuli; ○ = standard stimuli].
a = p < 0.05 between Cluster 1 and 2; b = p < 0.05 between Cluster 1 and 3;
c = p < 0.05 between Cluster 1 and 4; d = p < 0.05 between Cluster 2 and 3;
e = p < 0.05 between Cluster 2 and 4; f = p < 0.05 between Cluster 3 and 4.
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of the missed type. In patients with BMS, the missed
type error makes up the vast majority of lack of accu-
racy during the task. Since we have considered an error
type missed when no response to the target stimuli
occurred, or if the response occurred 700 ms after target
stimuli, then the lack of accuracy of patients with BMS
could be interpreted as a slowed cognitive processing on
attentional tasks.
Slower reaction times in MS patients have been fre-
quently reported [35,36] as well as frequent attentional
deficits [37,38], and a slowing of mental processing
independent of motor slowing has been suggested
[37,39,40]. This slowing of the speed of mental proces-
sing and other cognitive dysfunctions can already appear
early in the natural history of the disease, or even in
clinically isolated syndromes suggestive of MS [41,42]. It
can also be predictive of global cognitive decline [37]
and is particularly pronounced with visual and auditory
tasks [37,40,43].
The findings of our study suggest that subtypes of MS
disease may be associated with a moderate/severe atten-
tional impairment and with information processing defi-
c i t s .C o m p a r e dt oR R M Sp a t i e n t s ,B M Sp a t i e n t sw e r e
slower and less accurate, suggesting that BMS patients
could incur greater information processing impairments.
These deficits could be affecting attentional functions in
terms of attentional orienting and reorienting affecting
the BMS disease subtype more than other subtypes of
MS (such as RRMS) despite an apparent milder physical
disability.
Although our results have clearly shown that BMS
patients were slower and had less accuracy in visually
presented information processing than RRMS patients,
there are very few studies (most of them very recent)
that have explored or found evidence of altered cogni-
tive processing in the benign subtype of MS [9,10,44].
Furthermore, very few functional studies have tried to
assess different aspects of attentional processes and
information processing in MS patients with a benign
profile, using cognitive paradigms like the Posner para-
digm [28] or the Stroop paradigm [45].
Both RRMS and BMS patients may use different cog-
nitive strategies in task performance, although this sug-
gestion was not checked. For instance, some studies
have demonstrated that when patients with MS are pro-
vided with additional time to process information, they
perform as accurately as controls [36].
Event Related Potentials
The analyses of the ERP data also revealed some inter-
esting findings. In combination with these behavioural
data, electrophysiological results allow us to propose the
existence of distinct levels of altered stimulus processing
in MS patients, notably in attentional mechanisms and
different stages of information processing.
CNV period and ERP Amplitude
The topographical distribution of eCNV clearly sepa-
rates BMS patients from controls, but not from RRMS
patients. When regions are considered separately, eCNV
is smaller (amplitudes more positive-going) in BMS
patients than in controls at central and parietal but not
frontal sites. On the other hand, a striking finding of the
present study has been the more negative amplitude of
cCNV period at fronto-central sites that RRMS patients
showed in comparison to the control group but not the
BMS patients.
According to the functional hypothesis of early period
of CNV [15,46,47] current results may indicate a
reduced or worse activation of orientation and prepara-
tion mechanisms in BMS patients, after the presence of
a cue. RRMS patients, however, might be exhibiting an
increased attention at the beginning of the preparation
stage or greater task motivation since the amplitude of
CNV increases (more negative) with the force required
to make a response, as well as when more attention is
directed to the response [48,49]. These amplitude
abnormalities found in different temporal periods of
CNV both for BMS and RRMS patients may therefore
be revealing diverse neural mechanisms involved during
preparation performance, which may be affected in dif-
ferent degrees. However, both MS groups appear to
have the amplitude of the final period of CNV intact,
which is traditionally related to sensory preparation for
the imperative stimulus as well as to preparation for the
motor act.
Consistent with a large body of evidence, the CNV is a
sustained slow potential that develops during the inter-
val between two task-relevant stimuli, with the second
stimulus usually requiring a motor response [50,51].
After the initial response to the warning stimulus is
completed, an early negativity or eCNV develops over
prefrontal, precentral or parietal areas depending on the
task or paradigm used [52,53]. Specifically, a change on
eCNV amplitude has been observed when a spatial cue
is presented in comparison to when the cue is not pre-
sented. This finding has been functionally interpreted in
terms of activation of an executive mechanism control-
ling orientation or attention to a stimulus, assigning spe-
cific neural resources to the cued side and the posterior
tCNV and suitable preparation responses [46,52,53]. In
general, the main contributor to the CNV is the activa-
tion of fronto-parietal networks indicating the endogen-
ous attentional effort during the CNV period, and the
activation of the task-related neural set [15,16,47,54].
Regarding BMS patients, our findings related to CNV
seem to demonstrate that BMS patients, with the slow
advance of disease, could in turn develop deficits in the
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muli. When adopting the view that early CNV activity
(starting around 500 ms after cue onset) is indicative of
the start of cue orientation processes, whereas the later
CNV wave reflects expectation of the response and tar-
get location, it could be speculated that BMS patients
invest less effort or have a compromised attentional
mechanism in cue-orientation processes. Some of the
previously discussed cortical alterations found in MS
patients, which are linked to neural generators of CNV,
have been partly reported in recent studies with BMS
patients [9,10,45] and could be the reason that BMS
patients showed cognitive abnormalities beyond the
behavioural slowing that we have highlighted.
RRMS patients, however, appear to have good preser-
vation of the brain mechanisms indexed by the CNV,
showing even greater amplitude during the specific time
period of CNV. Previous studies have shown that the
CNV amplitude may be more negative when more
attention is focused on the task [46,48] and it is jointly
determined by the two processes of attention and arou-
sal [48]. Therefore, RRMS patients could be mobilizing
a greater amount of neural resources during initial peri-
ods of CNV (around mean 800 ms after cue onset)
related to expectation and preparation for cognitive and
behavioural responses.
Furthermore, this finding may also be connected to
other striking results related to the higher amplitude of
the LN component that RRMS patients obtained in
comparison to BMS patients. However, any interpreta-
tion regarding this finding should be cautious since the
only differences found were between the patient groups
but not between patients and controls. Neuroimaging
and electrophysiology studies have clarified some aspects
related to the usual neural sources for the LN wave and
other late ERP negativities during the performance of
different conflict task, including spatial conflict [55-57],
further indicating that the size of conflict is important
in the generation of associated cortical activity.
A first interpretation for the largest amplitude of LN
and cCNV in RRMS group could refer to an increase in
cortical activity and neural resources associated to
higher-order processing of stimuli. In this respect, the
amplitude of long-latency of ERP components is consid-
ered as an index of brain activity that is required during
a task, or proportional to the amount of attentional
resources devoted to a given task [58-60]. Consequently,
the higher LN amplitude for RRMS (and the lower
amplitude for BMS) as well as higher cCNV, could also
suggest the existence of compensatory cortical activation
and brain reorganization when these patients perform
attentional or memory tasks, in accordance with some
functional neuroimaging findings during performance of
the spatial tasks [61-64]. RRMS patients, therefore,
could be manifesting a particular brain organization or
increasing amounts of neural sources (indexed to higher
ERP amplitudes) involved in specific time periods which
relate to preparation performance and spatial conflict
monitoring in the Posner paradigm.
However, some limitations of our study do not allow
us to conclude this point of view. As far as we know,
there are no other studies that have previously assessed
the functional mean of CNV in MS, so we cannot com-
pare our results in MS patients with other studies.
Nevertheless, further studies should aim to explore and
verify these aspects.
Regarding amplitudes of other ERP components ana-
lyzed in our study, we tried to find the electrophysiolo-
gical correlates of the behavioural advantage of validly
cued targets. Typically, the P1 amplitude is enhanced to
valid cues. However, the control and the RRMS groups
showed greater amplitude to the valid condition com-
pared with BMS patients, suggesting that BMS patients
seem to have a lack of validity effect to amplitude P1
[28]. Some improvements, such as increasing the size of
our sample, might be made in future studies to deter-
mine better electrophysiological correlates of beha-
vioural valid effect.
In contrast to our current results, some authors have
reported frequent decrease of ERP component ampli-
tude in MS patients, but in particular for N2 and P3
waves and for the auditory modality. A decrease of
amplitude for P3 [65,66], for P2 and for P3 [18], for N2
and for P3 [67], for mismatch negativity complex and
P3 [68], or for P2 and N2 waves [19,69,70] has been
reported in MS patients. These results have been inter-
preted in terms of information processing difficulties
and an impairment on attentional orienting mechanisms
related with a disruption of the cortical-cortical or corti-
cal-subcortical neural connections which occurs as a
consequence of demyelination and axonal degeneration.
The reason for this apparent discrepancy with respect
to our amplitude-related findings could be due to the
fact that we included MS patients with a lower EDSS in
our study. Amplitude alterations seem to be more pro-
nounced in cognitively impaired patients or when
patients with high EDSS or secondary-progressive forms
are included [18,70]. It is commonly accepted, that in
advanced courses of MS and in patients with a high dis-
ability, the decrease of ERP amplitude could be a conse-
quence of widespread demyelination and axonal
degeneration in the brain of these patients, causing dis-
ruption of cortical-subcortical network connections and
their recruitment for neural activity [22,23]. However,
despite conservation of amplitude for standard ERP
components, the use of more refined cognitive para-
digms like the Posner paradigm could detect more ERP
abnormalities related to silent cognitive disturbances in
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tion of amplitude has been reported for traditional ERPs
components, but specific ERP components associated to
working memory paradigms showed a reduced ampli-
tude [41,71,72].
ERP Latency
Exploring the ERP latency results of our study allowed
us to observe that MS patients demonstrated an
increased latency in most ERP components analyzed.
Thus, our results showed an increased of P2, N2 and P3
latencies in both MS groups respect to healthy subjects.
Moreover, BMS patients obtained an increase of latency
for N1 and P3 components in comparison with RRMS
patients when standard stimuli were analysed (which
involved a higher number of stimuli than target condi-
tion). Consistent with our findings on amplitude or
behavioural measures, these differences seem to confirm
a greater alteration in cognitive processing for MS
patients with a benign profile. Increased ERP latencies
i nB M Sa sw e l la sR R M Sl e du st os u g g e s tt h a tE R P s
may indicate subtle degrees of cognitive dysfunction in
different courses of MS disease.
Thus, in all MS patients of our study, latencies of the
ERP components P2, N2, and P3 were longer than in
healthy subjects, which is quite consistent with the
results of previous studies. Most studies using an ERP
approach in MS have reported abnormalities of the
latency of ERP components, particularly for P3, both in
auditory modalities [17-21,66-68] and visual modalities
[28,70] or using both modalities [65,73,74]. Some of
these studies have also reported an increase in latencies
or a decrease in the amplitude for N1 component
[18,28], P2 component [17-19,21,67,69,70] or N2 com-
ponent [18-20,67,69,70]. Similarly, a longer latency for
more specific ERP components in working memory
paradigms and similar tasks has been found [41,70,71].
In this context, these discrepancies might result from
differences in the task or the degree of cognitive
abnormalities in the studied patients. Thus, when results
are divided in terms of different subtypes of MS,
patients with a chronic stage of disease or higher neu-
ropsychological impairment obtain more important
abnormalities on ERP latencies [18,21,41,65].
T h ec u r r e n ts t u d yi sh i g h l yc o m p a t i b l ew i t ht h ei d e a
that abnormalities in long-latency ERP components are
not simply due to a different processing speed in sen-
sory visual pathways, but the consequence of central
nervous system demyelination. In general, the great
majority of findings related to ERP latency abnormalities
[23,24] have been interpreted, either in terms of a con-
sequence of demyelinating lesions in primary afferent
pathways resulting in prolonged late ERP components
[17,18,21], or as a functional disconnection of
subcortical regions from higher cortical areas due to
demyelinating plaques [22,73,74].
Cluster analysis
The main aim of this analysis was to determine whether
there would be subtypes of MS patients based on differ-
ent combinations of their cognitive profile and psycho-
physiological pattern, and to investigate which
parameters have a greater weight to split these
participants.
Taking into account the measured psychophysiological
parameters of our study after performing a Posner-like
task, we may conclude that from the MS patients who
participated in our study, three distinct subgroups were
identified (typical relapsing-remitting course and benign
profile course): a “non-cognitive deficit” cluster grouped
with controls, a “mild cognitive deficit” cluster with
some psychophysiological abnormalities, and a “severe
cognitive deficit” cluster with widespread cognitive dys-
function. Furthermore, cluster analysis revealed two
more interesting findings: firstly, two control groups
could be created based on their younger age as well as
short ERP latencies, and secondly, some BMS patients
could not be clustered into any group (outliers patients)
due to their significant cognitive deficit.
Cluster 1 comprising 50% of controls was character-
ized by a good behavioural and psychophysiological per-
formance with a mean Z-score lower than the other
clusters in all measured domains. Participants of Cluster
2 accounted for the rest of healthy controls as well as
approximately 20% of RRMS and 10% BMS patients.
They were also characterized by a good behavioural per-
formance and normal psychophysiological measures.
Between these two clusters, compromising all controls
and very few MS patients, the difference demonstrated
by the cluster analysis solution was between the latency
of P2 and P3 components, which was very close to 1.5
or 2 standard deviations from Cluster 1 in these para-
meters. This discrepancy between both clusters that
took up all healthy subjects may be due mainly to the
fact that healthy participants of Cluster 1 were relatively
younger than controls of Cluster 2, although it was not
statically confirmed. One hypothesis offering a psycho-
physiological explanation is that of age-related effects on
the latencies of ERP components. There is strong evi-
dence that P3 latency (and less so for P2) appears to be
affected by age. On this basis, our findings are in line
with other authors who have reported a generic increase
in long-latency ERP components in controls with age
[75,76].
Most MS patients fell into the other two remaining
clusters. Thus, a majority of RRMS patients were
included in Cluster 3 (70% of our RRMS sample), while
Cluster 4 included a proportional clustering of RRMS
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performance in terms of CRs percentage and delay in
RTs, although they were also characterized by a moder-
ate-high increase of latency-scores in analyzed ERPs
(N1, P2 and P3) with respect to Cluster 1 and 2, show-
ing a mild delay in information processing and a non-
standard increase of neural activity in high-order pro-
cess (LN component) associated with periods after the
P3 component.
However, Cluster 4 demonstrated a global and
severely altered cognitive processing, characterized by
mean performances in the range of two or more stan-
dard deviations outside those of the control clusters, in
all scores measured. They were characterized by a gen-
eral cognitive delay, both from a behavioural perspec-
tive, with high RTs in their responses and an important
increase in numbers of errors (missed), as a widespread
slowing in information processing and abnormalities in
high-order processing.
Finally, a specific analysis for outlier cases removed
from the clustering procedure revealed that these out-
liers only belonged to BMS patients and they showed
severe impairment in terms of behavioural performance
(RTs and %CRs) and psychophysiological parameters
(latencies and amplitude) in the range of four or more
standard deviations from the controls. For a more
detailed description of cluster features, please see the
footnote in Figure 4.
Cluster analysis studies on ERP data are extremely
scarce, particularly for MS patients. To our knowledge
only one study has been published using cluster analysis
to describe cognitive subgroups in MS, but with a neu-
ropsychological approach [77]. Consistent with the find-
ings of this study, attentional and information
processing deficits may be reliable, early markers that
could be used to differentiate the unaffected from the
mildly cognitively impaired RRMS patients.
On the other hand, there seem to be some variables
that are more relevant than others for clustering the
participants of our study. The new ANOVA performed
with the clusters as between-subjects factors and psy-
chophysiological scores as within-subjects factors
revealed that, in general, latency parameters (N1, P2 and
particularly P3 components) were the strongest scores
for clustering patients. However, amplitude parameters,
probably due to the higher variability within them, seem
to be sensitive only to cluster splits formed mostly by
patients.
The behavioural performance in our attentional task
was also a sensitive variable for clustering patients, with
more than 2 standard deviations in the case of RTs, and
more than 3 for accuracy. Studies of attention in
patients with MS have observed reduced speed of infor-
mation processing, although accuracy is usually similar
to that of healthy subjects, indicating that differences in
accuracy between MS patients and controls are much
smaller than differences in speed [4,37,39,78]. Our
results confirm these results at least with RRMS
patients. However, when accuracy is in part determined
by time required for response, differences in accuracy
between MS patients and controls could be as important
as differences in speed for patients with many years of
disease and a benign MS profile.
Limitations and implications
Firstly, it should be noted that the cognitive abnormal-
ities assessed in the present study using the Posner task
might not be completely representative of the great vari-
ety and intensity of cognitive problems in MS. However,
the main purpose of including the attentional Posner
task is justified since attentional deficit and slowing of
speed mental processing appears between the most
impaired cognitive domains in this disease. Some varia-
tions of our experimental design may be taken into
account in order to improve the sensitivity of our task,
such as number, proportion and type of stimuli as inter-
trial time, or response time. Further studies on new Pos-
ner version tasks may also help clarify this issue [79]. In
addition, future studies employing a standard neuropsy-
chological assessment could help to elucidate differences
between specific cognitive domains. Conventional MRI
measures are also required in order to obtain a more
accurate interpretation of the relationship between MRI
abnormalities and neuropsychological and neurophysio-
logical cognitive function.
Another limitation in our study certainly comes from
the small sample size examined in the two subgroups of
MS, particularly in the benign group. Our patients may
not be fully representative of the overall group of BMS
subjects, and further studies including more patient
groups apart from the MS spectrum (e.g. clinically iso-
lated syndrome, secondary-progressive or primary forms
of MS) are needed to verify the exact functional role of
attentional and informationp r o c e s s i n gi nE R P sp a r a -
meters. Despite this, our findings are in line with other
studies that confirm the variability of the benign course
of MS. Finally, in order to assess our results from a
more global point of view, it would be particularly inter-
esting to perform the cluster analysis including a larger
set of clinical and paraclinical data in order to better
establish the ecological validity of a cognitive profile-
based classification of MS patients, as well as the rela-
tionship between ERP abnormalities and clinical
evidence.
Conclusions
The present study shows a number of significant differ-
ences between patients suffering from MS and age-
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visual-spatial Posner task with central cues. Our findings
revealed varying levels of attentional and information
processing in MS patients. When combined with beha-
vioural methods, ERPs can help to elucidate the neurop-
sychological mechanisms underlying the cognitive
impairments observed in this disease. Furthermore, after
adjusting for subject age, disease duration in MS
patients seems to be more closely related to alterations
of short-latency of the ERP (N1 and P2) and early stage
information processing. Abnormalities in the short-
latency of the ERP may therefore be a good marker of
specific information processing dysfunction in MS
patients with low disability but a long disease duration.
Our findings indicate that both MS groups of our
study have differentially altered patterns of cognitive
processing, and that these patients may develop diverse
degrees of altered cognitive processing. The characteris-
tics of the groups including BMS patients provide
empirical evidence about the heterogeneity of this dis-
ease course already suggested by electrophysiological
[28,29], neuroimaging [80] and follow-up studies [7,81].
In terms of psychophysiological abnormalities, RRMS
patients appear to form a more homogeneous clinical
entity whereas BMS patients appear to form a more het-
erogeneous one. RRMS patients show mild/moderate
alterations of cognitive processing, although some
patients could even develop several deficits particularly
related to slowing in information processing. The
greater degree of abnormalities such as delays in infor-
mation processing, orienting, and behavioural accuracy
for BMS patients, may be explained by a longer disease
duration and by a silent but continuous progression of
disease.
In addition, the present study indicates the importance
of differentiating MS groups according to cognitive
capacities. Whether there is a benign form of MS con-
tinues to be a controversial issue [2,10,81]. Our findings
also suggest, supported by evidence from neuroimaging
and neuropathology studies, that some patients diag-
nosed with BMS could have a less benign course, there-
fore our results are in line with clinical evidence which
suggests that the benign entity of MS can often be tem-
porary and later become disabling.
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